Evidence map›Paper›PMID 33682145›Full record

ArticleAlcoholism, clinical and experimental research2021

Effects of acetate on cerebral blood flow, systemic inflammation, and behavior in alcohol use disorder.

Jody Tanabe, Sarah Neff, Brianne Sutton, Sam Ellis, Luke Patten, Mark S Brown, Paula L Hoffman, Boris Tabakoff, Ellen L Burnham

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jody TanabeDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-7110-8444
Sarah NeffDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Brianne SuttonDepartment of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Sam EllisDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Luke PattenDepartment of Biostatistics and Informatics, School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Mark S BrownDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Paula L HoffmanDepartment of Pharmacology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Boris TabakoffDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0001-5132-5030
Ellen L BurnhamDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
University of Colorado Anschutz Medical Campus · USColorado School of Public Health · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
The Heritable Transcriptome and AlcoholismR24AA013162 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI HOFFMAN, PAULA, SABA, LAURA MAREN · 2001 to 2021
$14.2M
Supplement: CoPARC: Colorado Pulmonary Alcohol Research CollaborativeR24AA019661 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI ELLEN L BURNHAM · 2011 to 2026
$8.5M
Nezavist a Novel Molecule for Treatment of Alcohol Use DisorderU44AA024905 · NIAAA · LOHOCLA RESEARCH CORPORATION · PI TABAKOFF, BORIS · 2015 to 2021
$7.7M
A novel therapeutic to ameliorate chronic pain and reduce opiate useUG3DA047680 · NIDA · LOHOCLA RESEARCH CORPORATION · PI TABAKOFF, BORIS · 2019 to 2020
$5.7M
NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR002535NIAAA NIH HHS R24 AA013162NIAAA NIH HHS R24AA013162NIAAA NIH HHS R24 AA019661NIAAA NIH HHS R24AA019661NIAAA NIH HHS U44 AA024905NIDA NIH HHS UG3 DA047680
6 · The paper itself

Abstract

backgroundAlcohol use disorders (AUDs) are associated with altered regulation of physiological processes in the brain. Acetate, a metabolite of ethanol, has been implicated in several processes that are disrupted in AUDs including transcriptional regulation, metabolism, inflammation, and neurotransmission. To further understand the effects of acetate on brain function in AUDs, we investigated the effects of acetate on cerebral blood flow (CBF), systemic inflammatory cytokines, and behavior in AUD.

methodsSixteen participants with AUD were recruited from a nonmedical, clinically managed detoxification center. Each participant received acetate and placebo in a randomly assigned order of infusion and underwent 3T MR scanning using quantitative pseudo-continuous arterial spin labeling. Participants and the study team were blinded to the infusion. CBF values (ml/100 g/min) extracted from thalamus were compared between placebo and acetate using a mixed effect linear regression model accounting for infusion order. Voxel-wise CBF comparisons were set at threshold of p < 0.05 cluster-corrected for multiple comparisons, voxel-level p < 0.0001. Plasma cytokine levels and behavior were also assessed between infusions.

resultsFifteen men and 1 woman were enrolled with Alcohol Use Disorders Identification Test (AUDIT) scores between 13 and 38 with a mean of 28.3 ± 9.1. Compared to placebo, acetate administration increased CBF in the thalamus bilaterally (Left: 51.2 vs. 68.8, p < 0.001; Right: 53.7 vs. 69.6, p = 0.001), as well as the cerebellum, brainstem, and cortex. Older age and higher AUDIT scores were associated with increases in acetate-induced thalamic blood flow. Cytokine levels and behavioral measures did not differ between placebo and acetate infusions.

conclusionsThis pilot study in AUD suggests that during the first week of abstinence from alcohol, the brain's response to acetate differs by brain region and this response may be associated with the severity of alcohol dependence.

Indexed as

AcetatesAdultAge FactorsAlcohol AbstinenceAlcoholismBehaviorBrainCerebrovascular CirculationCytokinesFemaleHumansInflammationMagnetic Resonance ImagingMaleMiddle AgedPilot ProjectsAcetatesCytokinesacetatecerebral blood flowcytokinesmetabolites

Identifiers

PMID33682145
PMCPMC8496991
OpenAlexW3134536641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.